API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 3-(1-((3r)-3-(4-((4-(4-(3-(2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl)-5-fluorophenyl)piperazin-1-yl)phenyl)sulfamoyl)-2-(trifluoromethylsulfonyl)anilino)-4-phenylsulfanylbutyl)piperidine-4-carbonyl)oxypropylphosphonic Acid
2. Apg 1252
3. Apg-1252
4. Apg1252
1. Pelcitoclax [inn]
2. 317ubd60ml
3. 1619923-36-2
4. Unii-317ubd60ml
5. Pelcitoclax [who-dd]
6. Chembl4802151
7. Schembl15872908
8. Apg1252
9. Apg 1252 [who-dd]
10. Apg-1252
11. Nsc835773
12. Nsc-835773
13. Hy-109185
14. Cs-0116458
15. (r)-3-(1-(3-(4-(n-(4-(4-(3-(2-(4-chlorophenyl)-1-isopropyl-5-methyl-4-(methylsulfonyl)-1h-pyrrol-3-yl)-5-fluorophenyl)piperazin-1-yl)phenyl)sulfamoyl)-2-(trifluoromethylsulfonyl)phenylamino)-4-(phenylthio)butyl)piperidine-4-carbonyloxy)propylphosphonic Acid
16. 4-piperidinecarboxylic Acid, 1-((3r)-3-((4-(((4-(4-(3-(2-(4-chlorophenyl)-5-methyl-1-(1-methylethyl)-4-(methylsulfonyl)-1h-pyrrol-3-yl)-5-fluorophenyl)-1-piperazinyl)phenyl)amino)sulfonyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)-, 3-phosphonopropyl Ester
Molecular Weight | 1281.9 g/mol |
---|---|
Molecular Formula | C57H66ClF4N6O11PS4 |
XLogP3 | 7.5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 24 |
Exact Mass | 1280.3034690 g/mol |
Monoisotopic Mass | 1280.3034690 g/mol |
Topological Polar Surface Area | 275 Ų |
Heavy Atom Count | 84 |
Formal Charge | 0 |
Complexity | 2490 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |